Skip to content
Home/Companies/Biotech/Bindbridge
BI

Bindbridge

Biotech·United Kingdom·Active·0yr hold

Bindbridge is a biotech company, headquartered in United Kingdom.

Entry
2026
Hold
0yr
Status
Active
Est. EV
–

Who owns Bindbridge?

Bindbridge is currently owned by Nucleus Capital through Nucleus Capital II (2024 vintage), since 2026.

Hand-verified · updated 2026-07-03

Nucleus Capital
Investor
Nucleus Capital
Nucleus Capital II · 2024 · VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

More from Nucleus Capital II

Other portfolio companies in the same fund.

Triple Bio
Active
BiotechNetherlands· 2026
AtmoCooling
Active
EnergyUnited States· 2025
Ruby Bio
Active
BiotechUnited States· 2025
Spark E-Fuels
Active
EnergyGermany· 2025
Telura
Active
EnergyGermany· 2025
Apoha
Active
Deep TechUnited Kingdom· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings